Form 4 for CVS CVS Health
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001127602-22-009725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-17 | 2022-03-15 | CVS | Moriarty Thomas M | EVP, GC | S - Sale+OE | $105.00 | -51.4K | 836.8K | -6% | -$5.39M |
| D | 2022-03-17 | 2022-03-15 | CVS | Moriarty Thomas M | EVP, GC | M - OptEx | $102.26 | +51.4K | 888.1K | +6% | +$5.25M |
| D | 2022-03-17 | 2022-03-15 | CVS | Moriarty Thomas M | EVP, GC | M - OptEx | $0.00 | -51.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | S | D | 51,361 | $105.00 | 836,751 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-15 | M | A | 51,361 | $102.26 | 888,112 | D | — | — | (F1) All sales were effected pursuant to a Rule 10b5-1 plan. |
| 3 | Derivative | Stock Option | 2022-03-15 | M | D | 51,361 | $0.00 | 0 | D | $102.26 · 2016-04-01 to 2022-04-01 | 51,361 Common Stock | (F1) All sales were effected pursuant to a Rule 10b5-1 plan. (F2) Option became exercisable in four equal annual installments, commencing 4/1/2016. |